In support of these results, we have recently observed that repeated vaccination with irradiated autologous tumor vaccines did not maintain a long-term reduction of Foxp3+ Tregs in the peripheral blood of non-small cell lung cancer patients after lymphodepleting chemotherapy (Van den Engel et al., manuscript in preparation). This evidence concerns the gene FOXP3 and neoplasm.